Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

tender offer

9 posts
UUBS
UBS Raises Merck (MRK) Price Forecast as Part of Sector Preview
Read More

UBS Raises Merck (MRK) Price Forecast as Part of Sector Preview

  • 2026-04-17
Merck & Co., Inc. (NYSE:MRK) is included among the 10 Healthcare Stocks with Highest Dividends. UBS Raises Merck…
NNestlé
Basilea Pharmaceutica Ltd (BPMUF) Full Year 2025 Earnings Call Highlights: Strong Revenue ...
Read More

Nestlé Holdings, Inc. Announces the Pricing Terms of Cash Tender Offers for Any and All of its Certain Outstanding Notes

  • 2026-03-28
VEVEY, SWITZERLAND, March 17, 2026 (GLOBE NEWSWIRE) — Nestlé Holdings, Inc. (the “Issuer”), a wholly-owned indirect subsidiary of…
NNestlé
Basilea Pharmaceutica Ltd (BPMUF) Full Year 2025 Earnings Call Highlights: Strong Revenue ...
Read More

Nestlé Holdings, Inc. Announces Expiration and Results of Cash Tender Offers for Any and All of its Certain Outstanding Notes

  • 2026-03-22
VEVEY, SWITZERLAND, March 18, 2026 (GLOBE NEWSWIRE) — Nestlé Holdings, Inc. (the “Issuer”), a wholly-owned indirect subsidiary of…
NNestlé
Basilea Pharmaceutica Ltd (BPMUF) Full Year 2025 Earnings Call Highlights: Strong Revenue ...
Read More

Nestlé Holdings, Inc. Announces Commencement of Cash Tender Offers for Any and All of its Certain Outstanding Notes

  • 2026-03-14
VEVEY, SWITZERLAND, March 11, 2026 (GLOBE NEWSWIRE) — Nestlé Holdings, Inc. (the “Issuer”), a wholly-owned indirect subsidiary of…
RRoche
Roche’s Gazyva Meets Phase III SLE Endpoints at 52 Weeks
Read More

Roche to Acquire 89bio for $14.50/Share Plus $6 CVR

  • 2026-02-26
Roche (OTCQX: RHHBY) has initiated a tender offer to acquire all outstanding shares…
RRoche
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
Read More

Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH

  • 2026-02-25
F. Hoffmann-La Roche Ltd 89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated…
RRoche
Roche fenebrutinib Phase III hits PPMS disability goal
Read More

Roche Purchases 89bio Shares at $14.50 Plus Up to $6.00 CVR

  • 2026-02-21
Roche (OTCQX: RHHBY) announced that its subsidiary accepted for payment all shares validly…
RRoche
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
Read More

Roche purchases shares in tender offer for 89bio, Inc

  • 2026-02-18
F. Hoffmann-La Roche Ltd Basel, 30 October 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that…
RRoche
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
Read More

Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash

  • 2026-02-15
F. Hoffmann-La Roche Ltd Basel, 1 October 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that…
Switzerland
www.europesays.com